AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

1,3,7-Trimethylpurine-2,6-dione

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 10 USDMF, 9 CEP/COS, 11 JDMF, 1 KDMF, 18 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

388 FDF Dossiers, 126 FDA Orange Book, 15 Europe, 24 Canada, 128 South Africa, 95 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 100MG;1MG, TABLET;ORAL - 325MG;50MG;40MG, SUPPOSITORY;RECTAL - 100MG;2MG, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 14 Rochem International Inc, 31 SPI Pharma, 30 DKSH, 2 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 1 ICE Pharma, 16 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 21 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 46 BASF, 1 Bioplus Life Sciences, 4 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 15 Gangwal Chemicals, 1 Hayashibara, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 26 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 12 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 46 Roquette, 20 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

125 Fillers, Diluents & Binders, 66 Thickeners and Stabilizers, 66 Coating Systems & Additives, 57 Topical, 56 Solubilizers, 47 Disintegrants & Superdisintegrants, 45 Taste Masking, 44 Direct Compression, 37 Granulation, 36 Controlled & Modified Release, 36 Parenteral, 31 Film Formers & Plasticizers, 27 Lubricants & Glidants, 25 Chewable & Orodispersible Aids, 24 Emulsifying Agents, 21 Co-Processed Excipients, 18 Surfactant & Foaming Agents, 16 Rheology Modifiers, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Regulatory FDF Prices

MARKET PLACE

84 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 JP, 5 Others

ANALYTICAL

1 BioAnalytical Methods, 13 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
24/02/2025	CSPC New Nova Pharmaceutical	China	CSPC INNOVATION PHARMACEUTICAL CO., LTD. Shijiazhuang City CN	CEP 2014-254 - Rev 02	Caffeine	2024-07-17	Valid	Chemical		267
24/02/2025	CSPC New Nova Pharmaceutical	China	CSPC INNOVATION PHARMACEUTICAL CO., LTD. Shijiazhuang City CN	R1-CEP 2003-156 - Rev 00	Caffeine	2010-06-24	Withdrawn by EDQM Failure to CEP procedure	Chemical	2012-04-16	267

1,3,7-Trimethylpurine-2,6-dione

1,3,7-Trimethylpurine-2,6-dione

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers

10 USDMF

9 CEP/COS

11 JDMF

1 KDMF

18 NDC API

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

388 FDF Dossiers

126 FDA Orange Book

15 Europe

24 Canada

128 South Africa

95 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 100MG;1MG

TABLET;ORAL - 325MG;50MG;40MG

SUPPOSITORY;RECTAL - 100MG;2MG

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

14 Rochem International Inc

31 SPI Pharma

30 DKSH

2 Pharm-RX Chemical

10 Faran Shimi Pharmaceutical

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

1 ICE Pharma

16 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

21 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

46 BASF

1 Bioplus Life Sciences

4 Clariant

13 Corel Pharma Chem

7 DFE Pharma

3 Finar

15 Gangwal Chemicals

1 Hayashibara

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

5 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

26 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

12 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons